Biomaterials combined with cell therapy for treatment of spinal cord injury
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
22397610
DOI
10.2217/rme.11.121
Knihovny.cz E-zdroje
- MeSH
- biokompatibilní materiály farmakologie MeSH
- buněčná a tkáňová terapie * MeSH
- lékové transportní systémy MeSH
- lidé MeSH
- polymery farmakologie MeSH
- poranění míchy terapie MeSH
- tkáňové podpůrné struktury chemie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- biokompatibilní materiály MeSH
- polymery MeSH
Spinal cord injury (SCI) is a devastating traumatic injury resulting in paralysis or sensory deficits due to tissue damage and the poor ability of axons to regenerate across the lesion. Despite extensive research, there is still no effective treatment that would restore lost function after SCI. A possible therapeutic approach would be to bridge the area of injury with a bioengineered scaffold that would create a stimulatory environment as well as provide guidance cues for the re-establishment of damaged axonal connections. Advanced scaffold design aims at the fabrication of complex materials providing the concomitant delivery of cells, neurotrophic factors or other bioactive substances to achieve a synergistic effect for treatment. This review summarizes the current utilization of scaffolding materials for SCI treatment in terms of their physicochemical properties and emphasizes their use in combination with various cell types, as well as with other combinatorial approaches promoting spinal cord repair.
Citace poskytuje Crossref.org
Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
Biomaterials and Magnetic Stem Cell Delivery in the Treatment of Spinal Cord Injury
Injectable Extracellular Matrix Hydrogels as Scaffolds for Spinal Cord Injury Repair
Highly efficient magnetic targeting of mesenchymal stem cells in spinal cord injury